anastrozole has been researched along with Disease Models, Animal in 17 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacies of anastrozole and raloxifene on endometriosis." | 7.76 | Comparison of the effects of raloxifene and anastrozole on experimental endometriosis. ( Altintas, D; Cetinkaya, MB; Kandemir, B; Kokcu, A; Tosun, M, 2010) |
| "Combined therapy with BJD and alendronate can act synergistically against osteoporosis, which was possibly related to a reduced bone conversion rate through inhibiting bone resorption." | 3.85 | Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment. ( Guo, W; Huang, XH; Liang, RH; Su, L; Wang, CJ, 2017) |
| "To compare the efficacies of anastrozole and raloxifene on endometriosis." | 3.76 | Comparison of the effects of raloxifene and anastrozole on experimental endometriosis. ( Altintas, D; Cetinkaya, MB; Kandemir, B; Kokcu, A; Tosun, M, 2010) |
| "Endometriosis is defined as the growth of endometrial tissue outside of the uterine cavity." | 2.47 | The emerging use of aromatase inhibitors for endometriosis treatment. ( Nothnick, WB, 2011) |
| "1 mg/kg, and the clearance half-life of 7-16 h indicated that once-daily dosing would be possible in humans." | 2.40 | The relevance of preclinical models to the treatment of postmenopausal breast cancer. ( Dukes, M, 1997) |
| "Endometriosis is an oestrogen-dependent, inflammation-driven gynaecologic disorder causing severe disability." | 1.51 | Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model. ( Cohen, M; Marci, R; Pluchino, N; Poppi, G; Tille, JC; Wenger, JM; Yart, L, 2019) |
| " Long-term use of gonadotrophin-releasing hormone analogs, androgenes, and the danazol, which are widely used drugs for endometriosis, is usually not possible due to their suboptimal safety and tolerance profile." | 1.43 | Effect of imatinib on growth of experimental endometriosis in rats. ( Akkar, OB; Cetin, A; Kacan, SB; Kacan, T; Karakus, S; Ozer, H; Seker, M; Yildiz, C, 2016) |
| "Anastrozole treatment reversed the impaired bone morphogenetic protein receptor 2 pathway in females." | 1.40 | Sex-dependent influence of endogenous estrogen in pulmonary hypertension. ( Duggan, N; Fullerton, J; Hussey, MJ; Loughlin, L; MacLean, MR; Mair, KM; Nilsen, M; Roberts, S; Rowlands, DJ; Thomas, M; Wright, AF, 2014) |
| "Anastrozole-treated mice gained significantly more weight despite consuming significantly less hydration gel compared to vehicle treated mice." | 1.37 | A novel approach for long-term oral drug administration in animal research. ( Borgia, JA; Mufson, EJ; Overk, CR, 2011) |
| "Anastrozole treatment also attenuated urine albumin excretion by 42%, glomerulosclerosis by 30%, tubulointerstitial fibrosis by 32%, along with a decrease in the density of renal cortical CD68-positive cells by 50%, and protein expression of transforming growth factor-β by 20%, collagen type IV by 29%, tumor necrosis factor-α by 28%, and interleukin-6 by 25%." | 1.37 | Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats. ( Flynn, ER; Manigrasso, MB; Marbury, DC; Maric, C; Sawyer, RT, 2011) |
| "Treatment with anastrozole or letrozole was started on either postoperative day 1 or 28 and continued for 4 weeks." | 1.36 | Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. ( Barañao, RI; Bilotas, M; Meresman, G; Stella, I; Sueldo, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Chen, X | 1 |
| Austin, ED | 1 |
| Talati, M | 1 |
| Fessel, JP | 1 |
| Farber-Eger, EH | 1 |
| Brittain, EL | 1 |
| Hemnes, AR | 1 |
| Loyd, JE | 1 |
| West, J | 1 |
| Pluchino, N | 1 |
| Poppi, G | 1 |
| Yart, L | 1 |
| Marci, R | 1 |
| Wenger, JM | 1 |
| Tille, JC | 1 |
| Cohen, M | 1 |
| Mair, KM | 1 |
| Wright, AF | 1 |
| Duggan, N | 1 |
| Rowlands, DJ | 1 |
| Hussey, MJ | 1 |
| Roberts, S | 1 |
| Fullerton, J | 1 |
| Nilsen, M | 1 |
| Loughlin, L | 1 |
| Thomas, M | 1 |
| MacLean, MR | 1 |
| Yildiz, C | 1 |
| Kacan, T | 1 |
| Akkar, OB | 1 |
| Karakus, S | 1 |
| Seker, M | 1 |
| Kacan, SB | 1 |
| Ozer, H | 1 |
| Cetin, A | 1 |
| Huang, XH | 1 |
| Liang, RH | 1 |
| Su, L | 1 |
| Guo, W | 1 |
| Wang, CJ | 1 |
| Valeri, A | 1 |
| Ceccarelli, I | 1 |
| Fiorenzani, P | 1 |
| Aloisi, AM | 1 |
| Sgaragli, G | 1 |
| Pessina, F | 1 |
| Bilotas, M | 1 |
| Meresman, G | 1 |
| Stella, I | 1 |
| Sueldo, C | 1 |
| Barañao, RI | 1 |
| Altintas, D | 1 |
| Kokcu, A | 1 |
| Kandemir, B | 1 |
| Tosun, M | 1 |
| Cetinkaya, MB | 1 |
| Overk, CR | 2 |
| Borgia, JA | 1 |
| Mufson, EJ | 2 |
| Manigrasso, MB | 2 |
| Sawyer, RT | 2 |
| Marbury, DC | 1 |
| Flynn, ER | 2 |
| Maric, C | 1 |
| Nothnick, WB | 1 |
| Lu, PY | 1 |
| Wang, YT | 1 |
| Choi, J | 1 |
| Shaw, JW | 1 |
| Thatcher, GR | 1 |
| Hutchens, ZM | 1 |
| Maric-Bilkan, C | 1 |
| Kaya, U | 1 |
| Oktem, M | 1 |
| Zeyneloglu, HB | 1 |
| Ozen, O | 1 |
| Kuscu, E | 1 |
| Dukes, M | 1 |
| Lu, Q | 1 |
| Liu, Y | 1 |
| Long, BJ | 1 |
| Grigoryev, D | 1 |
| Gimbel, M | 1 |
| Brodie, A | 1 |
2 reviews available for anastrozole and Disease Models, Animal
| Article | Year |
|---|---|
The emerging use of aromatase inhibitors for endometriosis treatment.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Endometriosis; Endometrium; Estr | 2011 |
The relevance of preclinical models to the treatment of postmenopausal breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase I | 1997 |
15 other studies available for anastrozole and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Topics: Anastrozole; Animals; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Echocar | 2017 |
Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Cell Proliferation; Chick Embryo; Chorioallantoic Membra | 2019 |
Sex-dependent influence of endogenous estrogen in pulmonary hypertension.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Blotting, Western; Disease Models, Animal; Enzyme-Linked | 2014 |
Effect of imatinib on growth of experimental endometriosis in rats.
Topics: Anastrozole; Angiogenesis Inhibitors; Animals; Aromatase Inhibitors; bcl-2-Associated X Protein; Cel | 2016 |
Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment.
Topics: Alendronate; Alkaline Phosphatase; Anastrozole; Animals; Aromatase Inhibitors; Bone Density; Bone De | 2017 |
Effects of 17beta-estradiol on rat urinary bladder: gender differences in anoxia-glucopenia and reperfusion damage.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug | 2009 |
Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
Topics: Anastrozole; Animals; Apoptosis; Aromatase; Aromatase Inhibitors; Ascitic Fluid; Cell Proliferation; | 2010 |
Comparison of the effects of raloxifene and anastrozole on experimental endometriosis.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Endometriosis; Female; Nitriles; | 2010 |
A novel approach for long-term oral drug administration in animal research.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Anastrozole; Animal Experim | 2011 |
Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats.
Topics: Acute Kidney Injury; Albuminuria; Anastrozole; Animals; Aromatase Inhibitors; Collagen Type IV; Diab | 2011 |
Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anastrozole; Animals; Aromatase Inhibitors; Disease Models | 2012 |
Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.
Topics: Albuminuria; Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Collagen Type IV; Diabetes Melli | 2012 |
Impact of aromatase inhibitors on adhesion formation in a rat model.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Cytokines; Disease Models, Animal; Female; Medroxyproges | 2007 |
The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer.
Topics: Analysis of Variance; Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatas | 1999 |